Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study

(2019) Antonella Argentiero et al.   Cancers

Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State

(2019) Anna M. Nguyen et al.   MOLECULAR & CELLULAR PROTEOMICS

Targeting adenosine for cancer immunotherapy

(2018) Robert D. Leone et al.   Journal for ImmunoTherapy of Cancer

CD73 as a novel immune target and biomarker in pancreatic adenocarcinoma

(2018) N. Messaoudi et al.   HPB

Targeting adenosine in cancer immunotherapy: a review of recent progress

(2017) Theresa L Whiteside   Expert Review of Anticancer Therapy

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab

(2017) Silvana Morello et al.   Journal of Translational Medicine

Molecular Imaging of Immunotherapy Targets in Cancer

(2016) E. B. Ehlerding et al.   JOURNAL OF NUCLEAR MEDICINE

A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment

(2016) Akio Ohta   Frontiers in Immunology

Targeting CD73 in the tumor microenvironment with MEDI9447

(2016) Carl M. Hay et al.   OncoImmunology

Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment

(2016) Luca Antonioli et al.   OncoImmunology

Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers

(2015) Randy S Haun et al.   CANCER BIOLOGY & THERAPY

Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)

(2014) S. M. Cushman et al.   CLINICAL CANCER RESEARCH

Role of TGF-β Signaling in Generation of CD39+CD73+Myeloid Cells in Tumors

(2014) Sergey V. Ryzhov et al.   JOURNAL OF IMMUNOLOGY

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

(2014) J. Bastid et al.   Cancer Immunology Research

NT5E and FcGBP as key regulators of TGF-1-induced epithelial–mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer

(2013) Li Xiong et al.   CELL AND TISSUE RESEARCH

Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer

(2013) Chisato Yoshida et al.   PLoS One

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

(2013) S. Loi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma

(2013) Xiao-Xia Lu   WORLD JOURNAL OF GASTROENTEROLOGY

Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma

(2012) Paolo P. Provenzano et al.   CANCER CELL

CD73 as a novel prognostic biomarker for human colorectal cancer

(2012) Nan Liu et al.   JOURNAL OF SURGICAL ONCOLOGY

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer

(2012) Xian-Rui Wu et al.   JOURNAL OF SURGICAL ONCOLOGY

Accuracy and Precision of Radioactivity Quantification in Nuclear Medicine Images

(2012) Eric C. Frey et al.   SEMINARS IN NUCLEAR MEDICINE

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity

(2011) Sebastian F. M. Häusler et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

(2011) Long Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma

(2011) Anna Supernat et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Selection and analysis of anti-cancer antibodies for cancer therapy obtained from antibody phage library

(2010) Gene Kurosawa et al.   CANCER SCIENCE

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

(2010) J. Stagg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas

(2009) Katsumi Fukamachi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- and 90Y-Ibritumomab Tiuxetan

(2009) D. R. Fisher et al.   JOURNAL OF NUCLEAR MEDICINE

C-kit-targeted imaging of gastrointestinal stromal tumor using radiolabeled anti-c-kit monoclonal antibody in a mouse tumor model

(2009) Chizuru Sogawa et al.   NUCLEAR MEDICINE AND BIOLOGY

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

(2009) K. P. Olive et al.   SCIENCE

Isolation of antigen/antibody complexes through organic solvent (ICOS) method

(2008) Yasushi Akahori et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic

(2008) G. Kurosawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA